Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities
Authors
Keywords
-
Journal
Nanomaterials
Volume 4, Issue 3, Pages 813-826
Publisher
MDPI AG
Online
2014-09-12
DOI
10.3390/nano4030813
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors affecting therapeutic compliance: A review from the patient’s perspective
- (2016) Shu-Chuen Li Therapeutics and Clinical Risk Management
- Enhanced Efficacy and Broadening of Antibacterial Action of Drugs via the Use of Capped Mesoporous Nanoparticles
- (2013) Núria Mas et al. CHEMISTRY-A EUROPEAN JOURNAL
- Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis
- (2013) M. McGrath et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles
- (2012) Daniel L. Clemens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- In vivo oral toxicological evaluation of mesoporous silica particles
- (2012) Natalia Kupferschmidt et al. Nanomedicine
- Adjuvant Properties of Mesoporous Silica Particles Tune the Development of Effector T Cells
- (2012) Helen Vallhov et al. Small
- Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application
- (2012) C. Wu et al. Interface Focus
- In vivo Enhancement in Bioavailability of Atazanavir in the Presence of Proton-Pump Inhibitors using Mesoporous Materials
- (2011) Xin Xia et al. ChemMedChem
- Higuchi equation: Derivation, applications, use and misuse
- (2011) Juergen Siepmann et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
- (2010) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals
- (2010) Jie Lu et al. Small
- Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
- (2009) Joachim Brouwers et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- What does the cell see?
- (2009) Iseult Lynch et al. Nature Nanotechnology
- Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells
- (2009) Erika Witasp et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824
- (2008) Xiaojin Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport
- (2008) Randy Mellaerts et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- Sustained Release from Mesoporous Nanoparticles: Evaluation of Structural Properties Associated with Release Rate
- (2008) Ulrika Brohede et al. Current Drug Delivery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started